New test for Down’s raises important ethical questions
| Field | Value | Language |
| dc.contributor.author | Newson, A.J. | |
| dc.date.accessioned | 2015-01-12 | |
| dc.date.available | 2015-01-12 | |
| dc.date.issued | 2011-10-29 | |
| dc.identifier.citation | Newson, A. (2011) “New test for Down’s raises important ethical questions.” The Times. 28 October 2011. Available at: http://www.thetimes.co.uk/tto/health/article3209475.ece | en |
| dc.identifier.uri | http://hdl.handle.net/2123/12515 | |
| dc.description | newspaper article; section Analysis | en |
| dc.description.abstract | For a pregnant woman, easily and safely finding out for certain whether her baby will have Down’s syndrome is an attractive prospect. The point of non-invasive prenatal diagnosis (NIPD), as with current tests, is to give information about the health of the foetus. It’s just that this test is risk free and doesn’t need a needle to be inserted into a woman’s uterus. Should we worry about medicine making this test safer? This test is an amazing development. Imagine the heartbreak of having an invasive test to then miscarry as a result. But before we roll this test out across the NHS, we need to address important ethical questions. | en |
| dc.description.sponsorship | This article was written by Dr Ainsley Newson during the time of her employment with the University of Bristol, UK (2006-2012). Self-archived in the Sydney eScholarship Repository with permission of Bristol University, Sept 2014. | en |
| dc.language.iso | en | en |
| dc.publisher | The Times | en |
| dc.rights | Other | |
| dc.title | New test for Down’s raises important ethical questions | en |
| dc.type | Article | en |
| dc.type.pubtype | Publisher's version | en |
| usyd.faculty | Faculty of Medicine and Health, Sydney Health Ethics |
Associated file/s
Associated collections